Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Apple & Allergan top list of hedge fund positions

Wednesday, August 27, 2014

Bailey McCann, Opalesque New York:

S&P Capital IQ is out with its quarterly hedge fund tracker, ranking the positions of pure play hedge funds based on reported data including Form 13F. Report data finds that information technology and healthcare stocks saw the largest growth in new hedge fund buying activity during Q2 2014, with Allergan and Apple as the most popular individual stocks.

On a sector basis, IT stocks saw hedge fund flows of $1.45 billion leading the pack for the second quarter in a row. Healthcare was at second most popular, for the top 10 hedge funds with $1.4 billion. Financials down $2.25 billion, with a decrease in American International Group $686 and Crown Castle International $272.

Allergan Inc. was the top new buy among the largest 10 hedge funds with $1.43 billion in new positions, 6 funds holding it; 2 brand new funds bought the company, 2 increasing existing positions and 2 held their stake. The company is being aggressively pursued by Valeant Pharmaceuticals Intl Inc. (VRX) and Pershing Square Capital Management LP for a takeover.

Apple saw the second-highest level of new buying activity among hedge funds with $855 million in new buys in Q2. Last quarter it was the second top buy with $1.95 billion bought, but, also the second top sell with $871 million sold. This quarter, we see no such ambivalence. Also listing the top 100 po......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its